BioXplor is a company headquartered in Ireland. Brouky records 1 investor associated with the company.
BioXplor develops AI-driven data analytics platforms to improve drug discovery and clinical trial efficiency, focusing on rare and inflammatory diseases as well as cancer by leveraging real-world evidence and advanced analytics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.